Siderosis treatment

Siderosis Treatment Provided by the Lung Institute

Treatment for siderosis and related conditions is offered at the Lung Institute, where we exclusively treat lung disease using innovative cellular therapy. Siderosis, which is a type of interstitial lung disease, develops when iron particles are inhaled and deposited deep within the lungs. This condition is sometimes referred to as a benign form of pneumoconiosis, as it rarely causes symptoms like coughing and shortness of breath. Despite its lack of direct symptoms, however, siderosis can lead to other conditions that produce their own symptoms (including pneumonia and lung infections), which may require treatment.

The Lung Institute is proud to offer cellular therapy for symptoms of the conditions related to siderosis. Our cellular therapy for siderosis can be performed using the following method,  which offers certain advantages

  • Cellular Therapy

When providing treatment using cells, we begin by removing a small sample of a patient’s blood. We then separate the cells from the sample. Finally, we return the concentrated cells to the patient’s blood through an intravenous infusion. The Siderosis treatment method is performed in a clinical setting at one of our state-of-the-art facilities on an outpatient basis over the course of two days.

If you have been diagnosed with siderosis or a related condition and are interested in learning about the Lung Institute’s innovative cellular therapy methods, please call us today at 888-745-6697 so that we may answer your questions and provide you with additional information.

*For more information, go to

All claims made regarding the efficacy of Lung Institute's treatments as they pertain to pulmonary conditions are based solely on anecdotal support collected by Lung Institute. Individual conditions, treatment and outcomes may vary and are not necessarily indicative of future results. Testimonial participation is voluntary. Lung Institute does not pay for or script patient testimonials.

As required by Texas state law, the Lung Institute Dallas Clinic has received Institutional Review Board (IRB) approval from MaGil IRB, now Chesapeake IRB, which is fully accredited by the Association for the Accreditation of Human Research Protection Program (AAHRPP), for research protocols and procedures. The Lung Institute has implemented these IRB approved standards at all of its clinics nationwide. Approval indicates that we follow rigorous standards for ethics, quality, and protections for human research.

Each patient is different. Results may vary.